As professional antigen-presenting cells, DCs stimulate the anti-tumor effect of CD8 + T cells by presenting tumor antigens; however, M2 macrophage, Tregs, and CAFs could form immune barriers against CD8 + T cell-mediated anti-tumor immune responses [79, 80]. This evidence concerns the gene CD8A and neoplasm.